SBFM - Sunshine Biopharma Inc logo

SBFM

Sunshine Biopharma Inc

Rev โ€”top 1%10Y
Hold

Sunshine Biopharma Inc. develops life-saving medicines, focusing on oncology and antiviral therapies. It markets generic prescription drugs in Canada and is advancing proprietary treatments, including a protease inhibitor for SARS and a chemotherapy molecule for pancreatic cancer.

โš•๏ธ Healthcare NASDAQ Listed 2009 $ USD
$1,000 invested 10 years ago โ†’$0today

Score Overview

1 Year
Score
Net Growth-1.07%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-2.24%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score4.9
Net Growth51.44%
Net Trend20%
Net Income Consistencyโ€”
Rev Growth155x
Rev Trend80%
Revenue Consistencyโ€”
10 Years
Scoreโ€”
Net Growth-72.72%
Net Trend30%
Net Income Consistency
Rev Growthโ€”
Rev Trend70%
Revenue Consistency
All Time
Scoreโ€”
Net Growth-239x
Net Trend29%
Net Income Consistency
Rev Growthโ€”
Rev Trend62%
Revenue Consistency

See the full market ranking โ†’

Sunshine Biopharma Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 71.41K to $ 36M and net income went from -$ 2M to -$ 5M. Revenue increased in 4 of those 5 years; net income in 1.

Sunshine Biopharma Inc currently holds a 5-year HDB Score of 4.9 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 1.21โ€”
1 Year2025-08-12
$ 14.20-91.48%
5 Years2021-08-12
$ 539K-100.00%
10 Years2016-08-12
$ 1000K-100.00%
All Time2009-10-30
$ 1000K-100.00%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 35M-$ 6M$ 6M
2025$ 36M-$ 5M$ 9M
2024$ 34M-$ 5M$ 9M
2023$ 24M-$ 4M$ 16M
2022$ 4M-$ 26M$ 21M
2021$ 228.43K-$ 12M$ 2M
2020$ 71.41K-$ 2M$ 997.48K
2019$ 21.12K-$ 1M$ 48.09K
2018$ 447.2K-$ 2M$ 115.22K
2017$ 0.00-$ 1M$ 107.53K
2016$ 0.00-$ 3M$ 57.45K
2015$ 1.71K-$ 1M$ 50.8K
2014$ 0.00-$ 1M$ 143.42K
2013$ 0.00-$ 2M$ 31.24K
2012-$ 707.95K$ 132.64K
2011-$ 556.2K$ 60.69K
2010-$ 537.38K$ 162.39K
IPO2009-$ 25.02K$ 112.12K

Explore beyond SBFM

You're looking at Sunshine Biopharma Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies